Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy.

MLA

Marangon, Miriam, et al. “Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy.” Cancers, vol. 13, no. 2, Jan. 2021, p. 291. EBSCOhost, https://doi.org/10.3390/cancers13020291.

APA

Marangon, M., Visco, C., Barbui, A. M., Chiappella, A., Fabbri, A., Ferrero, S., Galimberti, S., Luminari, S., Musuraca, G., Re, A., Zilioli, V. R., & Ladetto, M. (2021). Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy. Cancers, 13(2), 291. https://doi.org/10.3390/cancers13020291

Chicago

Marangon, Miriam, Carlo Visco, Anna Maria Barbui, Annalisa Chiappella, Alberto Fabbri, Simone Ferrero, Sara Galimberti, et al. 2021. “Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy.” Cancers 13 (2): 291. doi:10.3390/cancers13020291.